XML 13 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 126,800 $ 9 $ 955,657 $ 261 $ (829,127)
Beginning balance (in shares) at Dec. 31, 2024   99,085,888      
Vesting of restricted stock units   906,712      
Stock-based compensation 8,351   8,351    
Unrealized loss on marketable securities (70)     (70)  
Net loss (40,471)       (40,471)
Ending balance at Mar. 31, 2025 94,610 $ 9 964,008 191 (869,598)
Ending balance (in shares) at Mar. 31, 2025   99,992,600      
Beginning balance at Dec. 31, 2024 126,800 $ 9 955,657 261 (829,127)
Beginning balance (in shares) at Dec. 31, 2024   99,085,888      
Net loss (70,995)        
Ending balance at Jun. 30, 2025 71,175 $ 9 971,192 96 (900,122)
Ending balance (in shares) at Jun. 30, 2025   101,212,329      
Beginning balance at Mar. 31, 2025 94,610 $ 9 964,008 191 (869,598)
Beginning balance (in shares) at Mar. 31, 2025   99,992,600      
Vesting of restricted stock units   1,111,421      
Purchase of common stock under employee stock purchase plan (in shares)   108,308      
Purchase of common stock under employee stock purchase plan 122   122    
Stock-based compensation 7,062   7,062    
Unrealized loss on marketable securities (95)     (95)  
Net loss (30,524)       (30,524)
Ending balance at Jun. 30, 2025 71,175 $ 9 971,192 96 (900,122)
Ending balance (in shares) at Jun. 30, 2025   101,212,329      
Beginning balance at Dec. 31, 2025 $ 30,649 $ 11 1,002,528 166 (972,056)
Beginning balance (in shares) at Dec. 31, 2025 110,362,581 110,362,581      
Vesting of restricted stock units   641,231      
Exercise of stock options $ 25   25    
Exercise of stock options (in shares)   21,375      
Stock-based compensation 2,908   2,908    
Unrealized loss on marketable securities (270)     (270)  
Net loss (22,930)       (22,930)
Ending balance at Mar. 31, 2026 10,382 $ 11 1,005,461 (104) (994,986)
Ending balance (in shares) at Mar. 31, 2026   111,025,187      
Beginning balance at Dec. 31, 2025 $ 30,649 $ 11 1,002,528 166 (972,056)
Beginning balance (in shares) at Dec. 31, 2025 110,362,581 110,362,581      
Net loss $ (45,920)        
Ending balance at Jun. 30, 2026 $ (9,970) $ 11 1,008,121 (126) (1,017,976)
Ending balance (in shares) at Jun. 30, 2026 111,656,805 111,656,805      
Beginning balance at Mar. 31, 2026 $ 10,382 $ 11 1,005,461 (104) (994,986)
Beginning balance (in shares) at Mar. 31, 2026   111,025,187      
Vesting of restricted stock units   583,920      
Exercise of stock options 2   2    
Exercise of stock options (in shares)   1,250      
Purchase of common stock under employee stock purchase plan (in shares)   46,448      
Purchase of common stock under employee stock purchase plan 48   48    
Stock-based compensation 2,610   2,610    
Unrealized loss on marketable securities (22)     (22)  
Net loss (22,990)       (22,990)
Ending balance at Jun. 30, 2026 $ (9,970) $ 11 $ 1,008,121 $ (126) $ (1,017,976)
Ending balance (in shares) at Jun. 30, 2026 111,656,805 111,656,805